Lupin appoints Brian Savage as President, Chief Legal Officer
SENSEX 72,690.98 -558.41 NIFTY 22,463.80 -223.85 CRUDEOIL 9,609.00 + 125.00 GOLD 142,560.00 -749.00 SILVER 196,333.00 -3,266.00 SENSEX 72,690.98 -558.41 NIFTY 22,463.80 -223.85 NIFTY 22,463.80 -223.85 CRUDEOIL 9,609.00 +…

-558.41
NIFTY 22,463.80-223.85
CRUDEOIL 9,609.00+ 125.00
GOLD 142,560.00-749.00
SILVER 196,333.00-3,266.00
SENSEX 72,690.98-558.41
NIFTY 22,463.80-223.85
NIFTY 22,463.80-223.85
CRUDEOIL 9,609.00+ 125.00
CRUDEOIL 9,609.00+ 125.00
GOLD 142,560.00-749.00
'; } document.getElementById("lgdv").innerHTML = htmlElements; } function numberformat(i) { return Number(parseFloat(i).toFixed(2)).toLocaleString('en', { minimumFractionDigits: 2 }) } async function gatherResponse(response) { const { headers } = response; const contentType = headers.get('content-type') || ''; if (contentType.includes('application/json')) { return await response.json() } return response.text(); } function getWidth() { if (Math.max(document.body.scrollWidth,document.documentElement.scrollWidth,document.body.offsetWidth,document.documentElement.offsetWidth,document.documentElement.clientWidth) > 991) { document.getElementById("mob").style.display = "none"; document.getElementById("lgdv").style.display = "block"; } else { document.getElementById("mob").style.display = "block"; document.getElementById("lgdv").style.display = "none"; } } getWidth(); THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.He joins Lupin from Teva Pharmaceuticals, where he held several senior leadership roles since 2015, serving most recently as executive vice president and interim global chief legal officer
By PTI
Updated - October 23, 2026 at 11:56 AM. | New DelhiBrian Savage
Global pharma major Lupin Ltd on Friday said it has appointed Brian Savage as President, Chief Legal Officer.
Savage will be based in New Jersey and lead the company's global legal, compliance and Intellectual Property Management Group (IPMG) functions, Lupin said in a release.
He joins Lupin from Teva Pharmaceuticals, where he held several senior leadership roles since 2015, serving most recently as executive vice president and interim global chief legal officer, it said.
"His deep understanding of the pharmaceutical industry landscape, extensive legal expertise and proven leadership will be valuable as we continue to strengthen our governance framework, navigate an evolving regulatory environment and advance our long-term growth ambitions," Lupin CEO Vinita Gupta and Managing Director Nilesh Gupta said, as per the release.
Published on October 23, 2026
THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.Sign into Unlock benefits!- Access 10 free stories per month
- Get notified by email for early preview to new features, discounts & offers
Figures reflect the source report and its stated period. This article is for information and is not investment advice.



